These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 12800986

  • 21. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy and safety compared to hydrochlorothiazide.
    Hegner G, Faust G, Freytag F, Meilenbrock S, Sullivan J, Bodin F.
    Eur J Clin Pharmacol; 1997; 52(3):173-7. PubMed ID: 9218922
    [Abstract] [Full Text] [Related]

  • 22. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 23. Treating systolic hypertension in the very elderly with valsartan-hydrochlorothiazide vs. either monotherapy: ValVET primary results.
    Izzo JL, Weintraub HS, Duprez DA, Purkayastha D, Zappe D, Samuel R, Cushman WC.
    J Clin Hypertens (Greenwich); 2011 Oct; 13(10):722-30. PubMed ID: 21974759
    [Abstract] [Full Text] [Related]

  • 24. Combination therapy with various combinations of aliskiren, valsartan, and hydrochlorothiazide in hypertensive patients not adequately responsive to hydrochlorothiazide alone.
    Geiger H, Barranco E, Gorostidi M, Taylor A, Zhang X, Xiang Z, Zhang J.
    J Clin Hypertens (Greenwich); 2009 Jun; 11(6):324-32. PubMed ID: 19527323
    [Abstract] [Full Text] [Related]

  • 25. AT1-receptor blockade improves augmentation index: a double-blind, randomized, controlled study.
    Klingbeil AU, John S, Schneider MP, Jacobi J, Weidinger G, Schmieder RE.
    J Hypertens; 2002 Dec; 20(12):2423-8. PubMed ID: 12473867
    [Abstract] [Full Text] [Related]

  • 26. A home blood pressure monitoring study comparing the antihypertensive efficacy of two angiotensin II receptor antagonist fixed combinations.
    Bobrie G, Delonca J, Moulin C, Giacomino A, Postel-Vinay N, Asmar R, COmparative Study of Efficacy of Irbesartan/HCTZ with Valsartan/HCTZ Using Home Blood Pressure Monitoring in the TreAtment of Mild-to-Moderate Hypertension (COSIMA) Investigators.
    Am J Hypertens; 2005 Nov; 18(11):1482-8. PubMed ID: 16280286
    [Abstract] [Full Text] [Related]

  • 27. Real-life effectiveness, safety, and tolerability of amlodipine/valsartan or amlodipine/valsartan/hydrochlorothiazide single-pill combination in patients with hypertension from Pakistan.
    Khan W, Moin N, Iktidar S, Sakrani J, Abid R, Afzal J, Maheshwary N, Kumar K, Siddiqi A, Qadir M.
    Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):45-55. PubMed ID: 24562476
    [Abstract] [Full Text] [Related]

  • 28. Combination therapy versus monotherapy as initial treatment for stage 2 hypertension: a prespecified subgroup analysis of a community-based, randomized, open-label trial.
    Everett BM, Glynn RJ, Danielson E, Ridker PM, Val-MARC Investigators.
    Clin Ther; 2008 Apr; 30(4):661-72. PubMed ID: 18498915
    [Abstract] [Full Text] [Related]

  • 29. A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study.
    Malacco E, Varì N, Capuano V, Spagnuolo V, Borgnino C, Palatini P, Val-Syst study.
    Clin Ther; 2003 Nov; 25(11):2765-80. PubMed ID: 14693303
    [Abstract] [Full Text] [Related]

  • 30. Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial.
    White WB, Calhoun DA, Samuel R, Taylor AA, Zappe DH, Purkayastha D.
    J Clin Hypertens (Greenwich); 2008 Jun; 10(6):450-8. PubMed ID: 18550935
    [Abstract] [Full Text] [Related]

  • 31. Combination antihypertensive therapy with valsartan and hydrochlorothiazide in Chinese patients with mild-to-moderate hypertension.
    Sun NL, Zhu JR, Zhao Y, Tu YM, Co-Diovan Trial Investigators.
    Curr Med Res Opin; 2008 Oct; 24(10):2863-71. PubMed ID: 18761785
    [Abstract] [Full Text] [Related]

  • 32. [Lowering of blood pressure, blood pressure amplitude and heart rate by treatment with valsartan or valsartan/hydrochlorothiazide. Results of an open observation study of 11,447 hypertensives].
    Weisser B, Vetter H, Mengden T.
    Dtsch Med Wochenschr; 2003 Mar 14; 128(11):541-4. PubMed ID: 12635025
    [Abstract] [Full Text] [Related]

  • 33. Time to achieve blood-pressure goal: influence of dose of valsartan monotherapy and valsartan and hydrochlorothiazide combination therapy.
    Weir MR, Levy D, Crikelair N, Rocha R, Meng X, Glazer R.
    Am J Hypertens; 2007 Jul 14; 20(7):807-15. PubMed ID: 17586417
    [Abstract] [Full Text] [Related]

  • 34. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
    Blood Press Monit; 2009 Jun 14; 14(3):112-20. PubMed ID: 19384192
    [Abstract] [Full Text] [Related]

  • 35. A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy.
    Ahn Y, Kim Y, Chang K, Kim W, Rhee MY, Cha KS, Hyon MS, Shim CY, Lee SY, Kim DI, Kim SW, Lim SW, Han KR, Jo SH, Lee NH, Kwan J, Ahn T.
    Medicine (Baltimore); 2018 Sep 14; 97(37):e12329. PubMed ID: 30212981
    [Abstract] [Full Text] [Related]

  • 36. Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension.
    Kochar M, Guthrie R, Triscari J, Kassler-Taub K, Reeves RA.
    Am J Hypertens; 1999 Aug 14; 12(8 Pt 1):797-805. PubMed ID: 10480473
    [Abstract] [Full Text] [Related]

  • 37. Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination.
    Schweizer J, Hilsmann U, Neumann G, Handrock R, Klebs S.
    Curr Med Res Opin; 2007 Nov 14; 23(11):2877-85. PubMed ID: 17922981
    [Abstract] [Full Text] [Related]

  • 38. Antihypertensive response to thiazide diuretic or angiotensin receptor blocker in elderly hypertensives is not influenced by pretreatment plasma renin activity.
    Weintraub HS, Duprez DA, Cushman WC, Zappe DH, Purkayastha D, Samuel R, Izzo JL.
    Cardiovasc Drugs Ther; 2012 Apr 14; 26(2):145-55. PubMed ID: 22311004
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of valsartan/hydrochlorothiazide fixed-dose combination compared with amlodipine monotherapy as first-line therapy for mild to moderate hypertension.
    Chao CL, Lin YH, Lin LC, Lin LY, Tsai CT, Wang YC, Hwang JJ, Chen JC, Chiang FT.
    J Int Med Res; 2009 Apr 14; 37(2):289-97. PubMed ID: 19383221
    [Abstract] [Full Text] [Related]

  • 40. Controlled trial of losartan given concomitantly with different doses of hydrochlorothiazide in hypertensive patients.
    Ruilope LM, Simpson RL, Toh J, Arcuri KE, Goldberg AI, Sweet CS.
    Blood Press; 1996 Jan 14; 5(1):32-40. PubMed ID: 8777471
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.